Symptomatic Improvement Within 3 Days With Tofacitinib Induction Therapy in Patients With Ulcerative Colitis: Results From OCTAVE Induction 1 and 2

被引：0
|
作者：
Hanauer, Stephen [1 ]
Panaccione, Remo [2 ]
Danese, Silvio [3 ]
Cheifetz, Adam [4 ,5 ,6 ]
Reinisch, Walter [7 ]
Higgins, Peter D. R. [8 ]
Woodworth, Deborah A. [9 ]
Zhang, Haiying [9 ]
Friedman, Gary S. [9 ]
Lawendy, Nervin [9 ]
Quirk, Daniel [9 ]
Nduaka, Chudy I. [9 ]
Su, Chinyu [9 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Humanitas Clin & Res Ctr, Rozzano, Lombardia, Italy
[4] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[5] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA
[6] Harvard Med Sch, Boston, MA USA
[7] Med Univ Vienna, Hamilton, ON, Canada
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Pfizer Inc, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-00609
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
609
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [21] Time to Loss of Efficacy Following Tofacitinib Interruption in Patients With Ulcerative Colitis: Results From OCTAVE Sustain
    Dubinsky, Marla C.
    Clarke, Kofi
    Klaus, Jochen
    Bouhnik, Yoram
    Soonasra, Arif
    Thorpe, Andrew J.
    Zhang, Haiying
    Friedman, Gary S.
    Woodworth, Deborah A.
    Lawendy, Nervin
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S405 - S406
  • [22] Frequency and Causes of Prolongation of the Induction Course of Tofacitinib in Patients with Ulcerative Colitis
    Oleg, Knyazev
    Anatoliy, Konoplyannikov
    Anna, Kagramanova
    Mariya, Zvyaglova
    Alexandra, Demchenko
    Anait, Babayan
    Albina, Lishchinskaya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1 - S1
  • [23] Tofacitinib induction efficiency and intracellular cytokine dynamics in ulcerative colitis: Results from clinical practice
    Kolar, M.
    Lukas, M.
    Malickova, K.
    Prochazkova, L.
    Bortlik, M.
    Duricova, D.
    Hruba, V.
    Machkova, N.
    Mitrova, K.
    Vasatko, M.
    Lukas, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S348 - S348
  • [24] Rectal bleeding and stool frequency improvement with tofacitinib retreatment in patients with Ulcerative Colitis after treatment interruption: Results from OCTAVE Open
    Allegretti, J. R.
    Gecse, K. B.
    Chiorean, M. V.
    Argollo, M.
    Guo, X.
    Lawendy, N.
    Su, C.
    Mundayat, R.
    Paulissen, J.
    Salese, L.
    Irving, P. M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I446 - I447
  • [25] Rectal bleeding and stool frequency improvement with tofacitinib retreatment in patients with Ulcerative Colitis after treatment interruption: Results from OCTAVE Open
    Allegretti, J. R.
    Gecse, K. B.
    Chiorean, M. V.
    Argollo, M.
    Guo, X.
    Lawendy, N.
    Su, C.
    Mundayat, R.
    Paulissen, J.
    Salese, L.
    Irving, P. M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I446 - I447
  • [26] Novel Use of Cyclosporine Induction Therapy as a Bridge to Tofacitinib in Severe Ulcerative Colitis
    Weisshof, Roni
    Swei, Eric
    Ollech, Jacob E.
    Sofia, M. Anthony
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1169 - S1169
  • [27] Diagnostic accuracy of rectal bleeding and stool frequency in predicting mucosal healing in patients with ulcerative colitis in the tofacitinib OCTAVE Phase 3 induction studies
    Colombel, J. F.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Kulisek, N.
    Santana, G. O.
    Lawendy, N.
    Ponce de Leon, D.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S328 - S329
  • [28] DIAGNOSTIC ACCURACY OF RECTAL BLEEDING AND STOOL FREQUENCY IN PREDICTING MUCOSAL HEALING IN PATIENTS WITH ULCERATIVE COLITIS IN THE TOFACITINIB OCTAVE PHASE 3 INDUCTION STUDIES
    Colombel, Jean Frederic
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Kulisek, Nicole
    Santana, Genoile O.
    Lawendy, Nervin
    de Leon, Dario Ponce
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2020, 158 (06) : S1203 - S1203
  • [29] Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments
    Feagan, Brian G.
    Vermeire, Severine
    Sandborn, William J.
    Reinisch, Walter
    Panes, Julian
    Tarabar, Dino
    Su, Chinyu
    Niezychowski, Wojciech
    Zhang, Haiying
    Friedman, Gary S.
    Woodworth, Deborah A.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S329 - S329
  • [30] Onset of Efficacy of Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Multinational, Phase 3 Clinical Trials
    Sandborn, William J.
    Danese, Silvio
    Panes, Julian
    Zhang, Haiying
    Woodworth, Deborah
    Marren, Amy
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - +
12345